This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

In-Vitro Diagnostic Substance Manufacturing Industry In The U.S. And Its International Trade [2013 Q3 Edition]

NEW YORK, Oct. 1, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [2013 Q3 Edition] http://www.reportlinker.com/p01598931/In-Vitro-Diagnostic-Substance-Manufacturing-Industry-in-the-US-and-its-International-Trade-[2013-Q3-Edition].html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_DiagnosticThis 2013 publication of In-Vitro Diagnostic Substance Manufacturing Industry report is the comprehensive market research guide for the industry. It contains the latest information on the industry's key financial data, competitive landscape, cost and pricing, and trends during the current environment, including the output and shipment changes over the past months.At 174 pages with over 150 charts and tables, the report covers topics such as current macroeconomic trends, granular product data, global trade, channel mix, government demand, and labor structure. It uses over a decade of historical data to forecast industry trends through 2017 on the domestic market, global market and overseas growth opportunities. This current report contains shipment data, inventory levels, international trade volume, and industry specific price indices available through June 2013. Industry analysts and Fortune 500 customers rely on this quarterly report to make accurate forecasts and planning in today's uncertain economy.In this report, you will find industry data on the following major categories: Executive Summary- Quick Industry Statistics: 2-page overview for the CEO on the run- Supply & Demand with Capacity Utilization- 2002-2012 11-Year Historical Shipment & Revenue- 2013-2017 5-Year Forecast

Industry Income Statement- All relevant financial data including: Revenue, Cost of Materials, Labor Costs, Gross Profit, SG&A, Net Income, etc.- 4-year Financials Comparison and Trends Industry Balance Sheet- Traditional key elements of Assets, Liabilities, and Equity- Inventory fabrication stages- Calculated balance sheet ratios

Capital Expenditure- Plant additions and expansions- Computer and IT investments- Machinery and Equipment for production and material handling

Industry Cost Analysis- Upstream Industries and the cost allocations towards producer, wholesale, retail, and freight - Materials and their percentage share of total material costs Industry Pricing Analysis- Producer Pricing Indices at industry, wholesale, and retail levels for comparison and trend forecasting- Pricing Distribution among Downstream Industries differentiated at producer, wholesale, retail, and freight categories

Industry Foreign Trade- Detailed Import/Export Data by commodities and by countries- Mode of Shipment and insurance and freight costs

Industry Structure- Labor and Compensation Structure: productivity indices, hourly wages, production hours, output index, HR structure- Establishments: Trends, Employee Statistics, State by State numbers- Valued added statistics: industry GDP contribution

Competitive Landscape- Industry Concentration: HHI, number of companies, size distributions, market shares- Major Players: company profiles and market size ranges

Definition & ClassificationThis U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices. This 6-digit NAICS industry (325413) is under the hierarchy of Pharmaceutical and Medicine Manufacturing Industry (32541), Chemical Manufacturing Subsector (325), and the Manufacturing Sector (31-33). Its SIC equivalent code is: 2835 - In Vitro and In Vivo Diagnostic Substances (in-vitro diagnostic substances). Revenue, Profitability & Foreign Trade PreviewThe industry's revenue for the year 2012 was reported at $12.6 billion USD, with an estimated gross profit of 43.66%. The industry used a projected 64 percent of its full production capacity in 2012. The industry could have increased its total shipment value to $19.6 billion USD under full production capacity. This industry did not have direct foreign trade statistics. The report nevertheless depicted relevant foreign trade data from a higher level NAICS industry or industry group. Report SummaryThis industry report contains 174 pages of in-depth market research with over 150 charts and tables. Presented are current and forecasted U.S. industry sales and shipment data, and its global trade statistics. For financial analysis, the report presents industry level income statements, balance sheets, and capital expenditure figures. In the cost analysis section, 43 upstream industries are analyzed to offer insight into the supply chain cost structure. For the channel and pricing structure, 17 downstream industries are analyzed. The competitive landscape section provides the number of companies and their respective revenue share, the market concentration, and a list of major players. Furthermore, products within the industry are listed with their respective market sizes and import and export data. The appendices contain relevant resources to additional trade statistics, U.S. State statistics, and industry trade associations.Our clients include Fortune 500 companies, manufacturers, international top consulting firms, major retailers and wholesalers, professional trade associations, financial corporations, universities, governmental entities, start-ups and individuals. We are committed to providing the highest level of quality to all our clients and assure your satisfaction in the report delivering as promised.

Preface IntroductionDefinitionRelated IndustriesComparison to U.S. Manufacturing SectorScopeHistory Executive SummaryQuick StatisticsSupply, Demand & Capacity Utilization2013 PreviewForeign Trade Shipments & Inventory 2013-2017 ForecastShipments Spending Per Capita Spending Per Household

Industry Income StatementRevenue (Value of Shipments, Net Sales)Compensation (Payroll & Fringe Benefits)SalariesWagesFringe BenefitsCompensation DistributionCost of MaterialsMaterials Cost Excluding Fuel & EnergyElectricity CostFuel CostsMaterials Consumption BreakdownGross ProfitOther CostsAdministrative, Sales and Marketing ExpensesCurrent and Deferred TaxesNet IncomeIncome (or Loss) From Operations (EBIT)Other Non-Operating IncomeIncome (or Loss) Before Income Taxes (NIBT)Income (or Loss) After Income TaxesEarnings before Interest, Depreciation & Taxes (EBIDT) Industry Balance SheetAssetsCash and Government SecuritiesAccounts ReceivableInventoriesInventories Stage of Fabrication RatiosTotal Current AssetsCurrent Assets Distribution ChartProperty and Other Non-Current AssetsLiabilitiesCurrent LiabilitiesTotal LiabilitiesEquityStockholders' EquityProfit on Stockholders' Equity before Income TaxProfit on Total Assets before Income TaxTotal Current Assets to Total Current LiabilitiesTotal Cash & Government Securities to Total Current Liabilities Capital ExpendituresBuilding & StructureMachine and Equipment Expenditures (including Automobile & Computers)ComputersAutomobile & HighwayOther Machine & Equipment Product Market Sizes Cost AnalysisUpstream Industries Pricing AnalysisProducer Price IndicesIndustry-Level Producer Price Indices Manufacturing Sector PPIProducer Price Index - Wholesale SectorProducer Price Index - Retail SectorConsumer Price Index - All ItemsConsumer Price Index - Durable GoodsConsumer Price Index - Non-Durable GoodsConsumer Price Index - ElectricityConsumer Price Index - GasolinePricing DistributionDownstream Industries Industry Foreign TradeImportImport ProcessHarmonized Tariff ScheduleTop Import Commodities AnalysisRanking - Countries US Imported FromTop 5 Countries US Imported FromTop 25 Countries US Imported FromImporting Insurance and Freight Cost Index by CountryImport Total Value from 2003 to 2015Import Total Quantity from 2003 to 2015Import Export Total Value Comparison from 2003 to 2015Import Export Total Quantity Comparison from 2003 to 2015Import Price Indices from 2003 to 2015Comparison of Import & Export Price Indices from 2003 to 2015ExportDomestic ExportsForeign Exports (Re-exports)Export Statistics SummaryTop Export Commodities AnalysisRanking - Countries US Exported ToTop 5 Countries US Exported ToTop 25 Countries US Exported ToExport Total Value from 2003 to 2015Export Total Quantity from 2003 to 2015Export Price Indices from 2003 to 2015 Industry StructureLabor and CompensationTrendProduction WorkersProduction Workers to Total Employees RatioHourly WagesProduction Hours TrendContribution (Revenue) per Production WorkerAnnual Wage per Production WorkerProduction Worker Contribution (Revenue) RatioRevenue to Number of WorkersLabor Productivity (output per hour)Labor Input Index (total labor hours)Output IndexUnit Labor Cost IndexLabor Compensation IndexOutput per Worker IndexAll Worker IndexHuman Resources - OccupationsEstablishmentsTrendAverage Number of Employees per EstablishmentContribution (Revenue) per EstablishmentEstablishment Sizes by Number of EmployeesEstablishments by U.S. StatesValue-AddedSustainability Competitive LandscapeIndustry ConcentrationIndustry AggregateMajor Players Appendix A - Additional Foreign Trade StatisticsTrading Countries' RankTop 5 US Trading Countries and OtherTop 25 US Trading Countries Appendix B - Industry U.S. States' StatisticsProduction Workers RatioAverage Hourly WageAverage Annual SalaryCost of Materials RatioCapital Expenditure RatioIndustry Shipment RatiosElectricity Consumption and Environmental ImpactFuel Consumption and Environmental Impact

Appendix C - Additional LinksTrade AssociationsTrade PublicationsTrade ShowsIndustry StandardsLegislation, Regulation, Tax and Environmental Related IssuesIndustry Specific Regulatory AgenciesNon-Industry Specific Regulatory Agencies

Appendix D - Industry's 4-Year Financial Statement Appendix E - Report MethodologyData Sourcing Data Collection & Integration Data Analysis Data Presentation Human Factors Legal

To order this report: In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [2013 Q3 Edition] http://www.reportlinker.com/p01598931/In-Vitro-Diagnostic-Substance-Manufacturing-Industry-in-the-US-and-its-International-Trade-[2013-Q3-Edition].html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

__________________________Contact Clare: clare@reportlinker.comUS: (339)-368-6001Intl: +1 339-368-6001

 

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,098.45 +18.88 0.11%
S&P 500 2,003.37 +6.63 0.33%
NASDAQ 4,580.2710 +22.5760 0.50%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs